NuVasive®, Inc.
A
A
NuVasive® To Participate In Investor Events In May 2015 NuVasive® Reports First Quarter 2015 Financial Results NuVasive® Launches Integrated Global Alignment (iGA™)  Platform At AANS 2015 NuVasive® Reaches Agreement In Principle To Settle OIG Matter NuVasive® To Launch Game-Changing Surgical Platform At The American Association Of Neurological Surgeons 83rd Annual Meeting

Media Contact

Stacy Roughan
Director, Investor Relations & Corporate Communications
858-909-1812
media@nuvasive.com

Fact Sheets

The NuVasive® corporate and procedural fact sheets can be viewed and downloaded below. The procedural fact sheets highlight our Maximum Access Surgery, or MAS®, platform. Maximum Access Surgery may significantly reduce surgery time and returns patients to activities of daily living much faster than conventional approaches.

NuVasive® Corporate Presentation

Download

NuVasive Corporate Fact Sheet

Download

XLIF® Fact Sheet

Download

MAS® TLIF Fact Sheet

Download

MAS® PLIF Fact Sheet

Download

Corporate Images

NuVasive® headquarters is located in San Diego, California with additional offices located in Memphis, Tennessee, and Paramus, New Jersey, as well as Puerto Rico, the United Kingdom, Germany, Italy, Australia, Singapore, and Japan. Both San Diego and Paramus locations have state-of-the-art cadaver operating theaters and training facilities focused on educating leading surgeons on advantages of NuVasive products and MAS®. High resolution corporate images can be viewed and downloaded below.

NuVasive® Headquarters

Download

NuVasive® O.R.

Download

NuVasive® Headquarters Aerial

Download

NuVasive® Headquarters Aerial

Download
 

Gregory T. Lucier

Chairman of the Board and Interim Chief Executive Officer

Gregory T. Lucier has served as our Chairman and Interim Chief Executive Officer since April 2015.  He has served as a member of the NuVasive Board of Directors since December 2013.  From May 2003 to February 2014, Mr. Lucier served as Chairman and Chief Executive Officer of Life Technologies, a global life sciences company acquired by Thermo Fisher Scientific in 2014.  During Mr. Lucier’s 11-year tenure at Life Technologies, he led the company from a small start-up known as Invitrogen in 2003, directed the acquisition and merger of Invitrogen with Applied Biosystems in 2008 into the renamed Life Technologies, and then transformed the organization by 2013 into a global, world-leading biotechnology firm with 50,000 products, 12,000 employees and nearly $4 billion in sales in more than 180 countries.  Serving in his leadership role, Mr. Lucier was responsible for fostering a culture of excellence at Life Technologies and applied his more than 25 years of strategic management experience to help champion an era of personalized medicine.  Mr. Lucier previously was a Corporate Officer of General Electric and served as an executive at GE Medical Systems. He received a bachelor’s degree in engineering from Pennsylvania State University and a masters of business administration from Harvard Business School.  In addition to serving on the Board of NuVasive, Mr. Lucier serves as the Board Chairman for Sanford Burnham Medical Research Institute and is a former director of CareFusion Corporation, now part of Becton, Dickinson & Co.

Product B-Roll

Watch our product B-Roll below

MAS® PLIF

View Video

XLIF®

View Video

MAS TLIF

View Video

XLIF Patient Animation

View Video

MAS PLIF Patient Animation

View Video

ALIF Patient Animation

View Video

PCF Patient Animation

View Video

MAS TLIF Patient Animation

View Video

ACDF Patient Animation

View Video